EUROPE AND MEA CULTURE TEST FOR HEALTHCARE ASSOCIATED INFECTIONS MARKET Size and trends

Europe and MEA Culture Test for Healthcare-associated Infections Market, By Product Type (Instruments, Reagents and Consumables), By Test Type (Bacterial Culture Tests, Aerobic Bacteria, Anaerobic Bacteria, Fungal Culture Tests, Viral Culture Tests, and Mixed Infection Tests), By Application (Surgical Site Infections, Bloodstream Infections, Urinary Tract Infections, Respiratory Infections, and Gastrointestinal Infections), By Sample Type (Blood, Urine, Stool, Tissue, and Others), By End User (Hospitals & Clinics, Nursing Homes, Diagnostic Laboratories, Research Institutions, Ambulatory Surgical Centers, and Others)

Published In : Mar 2025
Code : CMI7750
Pages :166
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Europe And Mea Culture Test For Healthcare Associated Infections Market Size and Trends

The Europe and MEA Culture Test for Healthcare-associated Infections Market is estimated to be valued at USD 299.1 Mn in 2025 and is expected to reach USD 370.3 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 3.1% from 2025 to 2032.

Key Takeaways of the Europe and MEA Culture Test for Healthcare-associated Infections Market:

In terms of product type, the instruments segment is estimated to account for the highest share of 52.2% of the Europe and MEA culture test for healthcare-associated infections market in 2025
In terms of test type, the bacterial culture tests segment is estimated to hold the highest market share of 34% of the Europe and MEA culture test for healthcare-associated infections market in 2025.
In terms of application, the surgical site infections segment is estimated to hold the highest market share of 27% of the market in 2025.

Market Overview:

The Europe and MEA culture test for healthcare-associated infections market is expected to witness moderate growth over the forecast period. The growing prevalence of hospital-acquired infections, such as pneumonia, urinary tract infections, and bloodstream infections, is expected to drive the demand for culture tests for early diagnosis and management. Additionally, increasing healthcare expenditure and rising awareness about the early detection of infections are further expected to support the market growth during the forecast period. However, the availability of alternative diagnostic tests and lack of skilled professionals may hamper the market growth to some extent.